Feasibility study of food containing Acanthopanax senticosus for cancer related fatigue
- Conditions
- Cancer related fatigue (malaise)
- Registration Number
- JPRN-UMIN000043988
- Lead Sponsor
- Health Sciences University of Hokkaido
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Not provided
#1 The patients who have taken Acanthopanax Senticosus and are not off it for more than 3 months. #2 Allergy to Acanthopanax Senticosus and/or chlorella and/or honey. #3 Breast, uterus and ovary cancer patient who are histologically confirmed with estrogen receptor positive. #4 The patient who received Doxifluridine (FURTULON) chemotherapy. #5 Uncontrolled hypertension (Blood pressure more than 180/90 mmHg) #6 Currently taking digoxin formulation. #7 Co-existence of severe complication. #8 Pregnant or expected to be pregnant, and breast feeding mother. #9 Co-existence of endometriosis and myoma uteri. #10 Unable to provide and written informed consent due to mental disorder. #11 Concomitant use of drugs which is contraindicated towards either Acanthopanax Senticosus or chlorella.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of the patient whose BFI can be evaluated at "visit 2".
- Secondary Outcome Measures
Name Time Method # The rate of improvement in cancer-related fatigue # The changes in laboratory data # Safety (The frequency of total adverse event)